Analgesic and Psychotropic Effects of a New Bradykinin Antagonist.

1,4-benzodiazepin-2-one analgesic effect potential neuropsychotropic effects risk of ulcerogenic effect

Journal

Bulletin of experimental biology and medicine
ISSN: 1573-8221
Titre abrégé: Bull Exp Biol Med
Pays: United States
ID NLM: 0372557

Informations de publication

Date de publication:
09 May 2024
Historique:
received: 14 08 2023
medline: 10 5 2024
pubmed: 10 5 2024
entrez: 9 5 2024
Statut: aheadofprint

Résumé

A bradykinin B

Identifiants

pubmed: 38724817
doi: 10.1007/s10517-024-06071-6
pii: 10.1007/s10517-024-06071-6
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© 2024. Springer Science+Business Media, LLC, part of Springer Nature.

Références

Gonçalves ECD, Vieira G, Gonçalves TR, Simões RR, Brusco I, Oliveira SM, Calixto JB, Cola M, Santos ARS, Dutra RC. Bradykinin receptors play a critical role in the chronic post-ischaemia pain model. Cell Mol. Neurobiol. 2021;41(1):63-78. doi: https://doi.org/10.1007/s10571-020-00832-3
doi: 10.1007/s10571-020-00832-3 pubmed: 32222846
Litvitsky PP. Inflammation. Vopr. Sovrem. Pediatr. 2006;5(4):75-81. Russian.
Marceau F, Bachelard H, Bouthillier J, Fortin JP, Morissette G, Bawolak MT, Charest-Morin X, Gera L. Bradykinin receptors: Agonists, antagonists, expression, signaling, and adaptation to sustained stimulation. Int. Immunopharmacol. 2020;82:106305. doi: https://doi.org/10.1016/j.intimp.2020.106305
doi: 10.1016/j.intimp.2020.106305 pubmed: 32106060
Andronati SA, Pavlovsky VI, Golovenko MYa, Reder AS, Larionov VB, Valivodz’ IP. Synthesis and extraction efficiency from biological fluids of [214C]Propoxazepam: a potent analgesic with multifunctional mechanism of action. JCBPS. Section A. 2019;9(4):323-333. doi: https://doi.org/10.24214/jcbps.A.9.4.32333
Pavlovskij VI, Khazanov VA, Stankevich SA. Patent RU No. 2701557. 1,4-Benzodiazepin-2-one derivatives and use thereof. Bull. No. 15. Published September 30, 2019.
Hasani A, Soljakova M, Jakupi M, Ustalar-Ozgen S. Preemptive analgesic effects of midazolam and diclofenac in rat model. Bosn. J. Basic Med. Sci. 2011;11(2):113-118. doi: https://doi.org/10.17305/bjbms.2011.2593
doi: 10.17305/bjbms.2011.2593 pubmed: 21619559 pmcid: 4362585
Bandapati S, Podila KS, Yadala VR. Comparative study of anti-nociceptive effect of venlafaxine with tramadol by tail-flick test in animal model of mice. Natl J. Physiol. Pharm. Pharmacol. 2021;11(6):633-637. doi: https://doi.org/10.5455/njppp.2021.11.11307202001022021
doi: 10.5455/njppp.2021.11.11307202001022021
Manual for Preclinical Studies of New Pharmacological Substances. Mironov AN, ed. Moscow, 2012. Russian.
Molodavkin GM, Voronina TA, Chernyavskaya LI, Burlakova EB, Khorseva NI, Seredenin SB. Pharmacological activity of phenazepam and flunitrazepam in ultralow doses. Bull. Exp. Biol. Med. 2003;135(Suppl. 7):39-41. doi: https://doi.org/10.1023/a:1024710225445
doi: 10.1023/a:1024710225445 pubmed: 12949644
Shi Z, Pan S, Wang L, Li S. Oleanolic acid attenuates morphine withdrawal symptoms in rodents: association with regulation of dopamine function. Drug Des. Devel. Ther. 2021;15:3685-3696. doi: https://doi.org/10.2147/DDDT.S326583
doi: 10.2147/DDDT.S326583 pubmed: 34465980 pmcid: 8402955

Auteurs

A E Aliforenko (AE)

Innovative Pharmacology Research LLC, Tomsk, Russia.
Siberian State Medical University, Ministry of Health of the Russian Federation, Tomsk, Russia.

V S Motov (VS)

Innovative Pharmacology Research LLC, Tomsk, Russia.

V V Bykov (VV)

Innovative Pharmacology Research LLC, Tomsk, Russia. vladimir.b.1989@gmail.com.
Siberian State Medical University, Ministry of Health of the Russian Federation, Tomsk, Russia. vladimir.b.1989@gmail.com.

A V Bykova (AV)

Innovative Pharmacology Research LLC, Tomsk, Russia.

V I Pavlovsky (VI)

Innovative Pharmacology Research LLC, Tomsk, Russia.

V V Larchenko (VV)

Innovative Pharmacology Research LLC, Tomsk, Russia.
Siberian State Medical University, Ministry of Health of the Russian Federation, Tomsk, Russia.

V A Khazanov (VA)

Innovative Pharmacology Research LLC, Tomsk, Russia.

A I Vengerovskii (AI)

Siberian State Medical University, Ministry of Health of the Russian Federation, Tomsk, Russia.

Classifications MeSH